Pharmacovigilance related activities of Member States and the European Medicines Agency concerning medicinal products for human use (2012 – 2014) — Update.
On 8 August 2016 the Commission adopted a report on the pharmacovigilance related activities of Member States and the European Medicines Agency (EMA). The report and the accompanying staff working document which describe the main activities of the collaborative EU system for monitoring and managing the safety of human medicines since the new legislation came into effect in 2012 until 2014 are available in publication format here: Report
The original version in all the EU official languages remains available here: Report
Smarsh, Inc. assumes no liability for the accuracy or completeness of this information. Please consult with an attorney for specific information on specific rules and regulations and how they apply to your business.